Skip Navigation

Publication Detail

Title: SHP-1 is directly activated by the aryl hydrocarbon receptor and regulates BCL-6 in the presence of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).

Authors: Phadnis-Moghe, Ashwini S; Li, Jinpeng; Crawford, Robert B; Kaminski, Norbert E

Published In Toxicol Appl Pharmacol, (2016 Nov 01)

Abstract: The environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), which is a strong AHR agonist, causes significant suppression of human B cell activation and differentiation. The current studies describe the identification of Src homology phosphatase 1 (SHP-1) encoded by the gene PTPN6 as a putative regulator of TCDD-mediated suppression of B cell activation. Shp-1 was initially identified through a genome-wide analysis of AHR binding in mouse B cells in the presence of TCDD. The binding of AHR to the PTPN6 promoter was further confirmed using electrophoretic mobility shift assays in which, specific binding of AHR was detected at four putative DRE sites within PTPN6 promoter. Time-course measurements performed in human B cells highlighted a significant increase in SHP-1 mRNA and protein levels in the presence of TCDD. The changes in the protein levels of SHP-1 were also observed in a TCDD concentration-dependent manner. The increase in SHP-1 levels was also seen to occur due to a change in early signaling events in the presence of TCDD. We have shown that BCL-6 regulates B cell activation by repressing activation marker CD80 in the presence of TCDD. TCDD-treatment led to a significant increase in the double positive (SHP-1(hi) BCL-6(hi)) population. Interestingly, treatment of naïve human B cells with SHP-1 inhibitor decreased BCL-6 protein levels suggesting possible regulation of BCL-6 by SHP-1 for the first time. Collectively, these results suggest that SHP-1 is regulated by AHR in the presence of TCDD and may, in part through BCL-6, regulate TCDD-mediated suppression of human B cell activation.

PubMed ID: 27546522 Exiting the NIEHS site

MeSH Terms: Animals; B-Lymphocytes/metabolism; Enzyme Activation; Humans; Lymphocyte Activation; Mice; Polychlorinated Dibenzodioxins/toxicity*; Promoter Regions, Genetic; Protein Tyrosine Phosphatase, Non-Receptor Type 6/genetics; Protein Tyrosine Phosphatase, Non-Receptor Type 6/metabolism*; Proto-Oncogene Proteins c-bcl-6/metabolism*; RNA, Messenger/genetics; Receptors, Aryl Hydrocarbon/physiology*

Back
to Top